Auxly Cannabis reports CA$13.5 million loss on record revenue

(This story has been updated to replace the year-to-date loss in the first sentence with the quarterly loss.)

Marijuana producer Auxly Cannabis Group reported record revenue for the three months ended Sept. 30, although the company lost 13.5 million Canadian dollars ($10.7 million), according to financial results the company released Monday.

The Toronto-based company’s adjusted EBITDA of negative CA$6.5 million was below analysts’ consensus expectations.

Despite the loss, the company said it still aims to be profitable on an adjusted basis by the end of this year, however, “operational challenges” are expected to make that a difficult goal to achieve.

Absent unexpected improvements in equipment delivery and other timelines, Auxly said it now believes a more realistic time frame is the first half of next year.

Net revenue of CA$24.5 million in the quarter was 17% higher than the previous three-month period and 95% more than the same period last year.

Sales comprised of roughly:

  • CA$16.9 million of Cannabis 2.0 products (including edibles and extracts).
  • CA$7.6 million of Cannabis 1.0 product sales (including dried cannabis and oil).

Citing figures from Headset, Auxly said it had the sixth-most market share in Canada in the quarter, or 5.6% of national recreational retail sales.

MJBizDaily Indoor Cultivation Buyers Guide – Now available!

Master the complexities of growing cannabis indoors with fundamental tips and guidance from experienced cultivation professionals.

Featured inside:

  • Best practices in cultivation facility design
  • Tips for mapping out a climate control system and purchasing components
  • Indoor cultivation buyers guide checklist
  • And more!

In October, the company said that it rose to 7.3% of Canada’s adult-use market.

All of Auxly’s revenue is from its Canadian operations.

Auxly’s inventory consists of:

  • Dried cannabis (CA$10.8 million).
  • Dried hemp (CA$3.8 million).
  • Cannabis oil (CA$11.8 million).
  • Generation 2 derivative products (CA$10 million).
  • Merchandise (CA$281,000).
  • Packaging, hardware, consumables and ingredients (CA$16.1 million).

Approximately CA$700,000 of impaired inventory in the three months stemmed from packaging no longer in use, the company said.

Another impairment of CA$716,000 on cannabis inventory was recognized.

Auxly’s outlook for the rest of the year includes exploring possible entry into international markets on an “asset light” basis.

In early November, Auxly appointed Murray McGowan to its board, a move made in conjunction with the company’s strategic partnership with British multinational tobacco firm Imperial Brands.

McGowan is chief strategy and development office for Imperial.

Shares of Auxly Cannabis Group are traded on the Toronto Stock Exchange as XLY.